Dual Infection with Human Immunodeficiency Virus Type 1 and Type 2: Impact on HIV Type 1 Viral Load and Immune Activation Markers in HIV-Seropositive Female Sex Workers in Abidjan, Ivory Coast

2000 ◽  
Vol 16 (14) ◽  
pp. 1371-1378 ◽  
Author(s):  
John N. Nkengasong ◽  
Luc Kestens ◽  
Peter D. Ghys ◽  
Stéphania Koblavi-Dème ◽  
Ronald A. Otten ◽  
...  
2000 ◽  
Vol 7 (6) ◽  
pp. 987-989 ◽  
Author(s):  
R. Kannangai ◽  
S. Ramalingam ◽  
K. J. Prakash ◽  
O. C. Abraham ◽  
R. George ◽  
...  

ABSTRACT Nested PCRs for human immunodeficiency virus type 1 (HIV-1) and HIV-2 were compared with immunoblot test results. Twelve of 13 immunoblot-positive HIV-2 samples were positive by PCR. There were five INNO-LIA (Innogenetics, Zwijnaarde, Belgium) and/or HIVBLOT 2.2 (Genelabs, Singapore) samples that tested positive for dual infection. HIV-1 PCR was positive in all samples, while HIV-2 PCR was positive in two and RIBA (Chiron Corporation, San Diego, Calif.) was positive for HIV-2 in three samples. Thus the prevalence of HIV-2 is accurately estimated by the use of immunoblotting, but that of HIV-1 and -2 dual infection may be overestimated.


1999 ◽  
Vol 15 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Dennis L. Ellenberger ◽  
Danuta Pieniazek ◽  
John Nkengasong ◽  
Chi-Cheng Luo ◽  
Sushil Devare ◽  
...  

2010 ◽  
Vol 26 (2) ◽  
pp. 123-131 ◽  
Author(s):  
Sodsai Tovanabutra ◽  
Eduard J. Sanders ◽  
Susan M. Graham ◽  
Mary Mwangome ◽  
Norbert Peshu ◽  
...  

2012 ◽  
Vol 28 (4) ◽  
pp. 357-365 ◽  
Author(s):  
Deogratius Ssemwanga ◽  
Nicaise Ndembi ◽  
Fred Lyagoba ◽  
Justine Bukenya ◽  
Janet Seeley ◽  
...  

1995 ◽  
Vol 172 (5) ◽  
pp. 1371-1374 ◽  
Author(s):  
P. D. Ghys ◽  
M. O. Diallo ◽  
V. Ettiegne-Traore ◽  
K. M. Yeboue ◽  
E. Gnaore ◽  
...  

1995 ◽  
Vol 4 (5) ◽  
pp. 315-321
Author(s):  
M. Clerici ◽  
M. L. Villa ◽  
D. Trabattoni ◽  
G. M. Shearer

The acquired immunodeflciency syndrome (AIDS) is a clinically multifaceted disease induced by infection with the human immunodeficiency virus (HIV). HIV infection results in a complex pattern of immunologic alterations that leads to the development of AIDS in the majority of HIV seropositive (HIV+) individuals. The reduction in CD4 T lymphocyte counts is the hallmark of HIV infection; nevertheless, long before the reduction in CD4 counts reaches critical levels, a series of profound and complex defects that impair the function of CD4 T lymphocytes can be detected. Thus, HIV infection is characterized by quantitative and qualitative defects affecting CD4 T lymphocytes. It was suggested recently that programmed cell death (PCD) is an important mechanism leading to CD4 depletion in HIV infection, and that susceptibility of peripheral lymphocytes to PCD is differentially regulated by diverse cytokines. Thus, type 1 cytokines would protect CD4 lymphocytes against PCD, whereas type 2 cytokines would not protect against, and could augment, PCD. We suggest that the qualitative alterations of the immune response provoke the CD4 depletion characteristic of HIV disease via type 2 cytokinemediated augmentation of PCD, and are therefore ultimately responsible for the progression of HIV infection. Finally, we summarize recent data showing that three correlates of disease progression: emergence of HIV strains with syncitium-inducing ability (SI), type 1-to-type 2 cytokine shift, and CD4 depletion, are significantly associated, suggesting a complex interconnected virologic-immunologic pathogenesis of HIV infection.


Sign in / Sign up

Export Citation Format

Share Document